Sara Szal MD
Tens of millions of women worldwide have breast implants, with an estimated 1.5 million prostheses implanted annually. [1] The majority of those women were never given a complete picture of what they were agreeing to when they signed the consent form and went under anesthesia.
I am one of them.
I had implants placed after a prophylactic mastectomy. I carry a hereditary cancer risk that made removing my breast tissue a rational decision, the kind of decision medicine calls proactive and I call the worst kind of necessary. (Details are in my posts over the past week, here and here.)
Reconstruction was presented as the obvious next step but at the time, no doctor described it as exchanging one biological risk for another. No one explained the emerging research on immune dysregulation, inflammatory signaling, or implant-associated malignancies. I signed the form and was told I had made the right decision.
Then I began seeing a pattern in clinical practice.
A woman would see her doctor with fatigue, joint pain, brain fog, hair loss, and rashes that no specialist could explain. She would see multiple doctors and be told the diagnosis was unclear. Eventually, someone referred her to psychiatry and treated her for anxiety, a diagnosis that required no further investigation.
No one asked whether her implants might be contributing or looked for genetic susceptibility to breast implant illness, impaired processing of inflammatory compounds, or anti-nuclear antibodies in her blood.
We talk a lot about what women will do for beauty, from fillers to implants to face lifts. We talk much less about the pressure that shapes those choices in the first place.
Women learn early that their bodies are supposed to be improved. Breasts should be fuller, higher, symmetrical, youthful, and perky. By the time a woman considers implants, the choice is rarely hers alone, it has been shaped by years of media influence, advertising, cultural judgment, and an industry built around the idea that the natural female body is somehow not enough.
After mastectomy, the decision can feel even less like a choice. You are frightened, grieving, and trying to recognize yourself again. Reconstruction is often presented as the path back to normal. The risks may be mentioned, but they are not always explained in a way that allows a woman to understand what they could mean for her body years later. Few women are given the option of “going flat” (flat closure) or autologous (flap) reconstruction. (My surgeon told me the autologous reconstruction would require 2 to 3 days in the ICU for “flap watch.” That sounded like a terrible choice.)
The medical system profits from putting implants in women. Then, when some of those women became sick, many are told their problem is anxiety and sent to psychiatrists.
This essay is about that failure. It is also about what the science now shows, the biomarkers being identified, the diagnostic framework taking shape, and the clinical approach I have developed over years of caring for women who are still searching for an explanation.
I am writing it because the gap between the research and what many physicians still tell patients is enormous, and because I signed one of those consent forms myself. I know what it said but I also know what it left out.
Fatigue so severe she had stopped exercising. Joint pain that moved: hips one week, wrists the next. Brain fog she described as thinking through wet concrete. Hair coming out in the shower in quantities that frightened her. Rashes that appeared without explanation and disappeared without treatment. A low-grade depression she had never experienced before.
She had been to multiple physicians over the years. A rheumatologist ruled out lupus, an endocrinologist found her thyroid normal, a neurologist found nothing structural. A gastroenterologist attributed her GI symptoms to stress. Her gynecologist suggested perimenopause.
None of them asked about her breast implants.
She had silicone gel implants placed at 34 for cosmetic augmentation. She was 41 when I saw her. The implants had been in for seven years. I asked about them because I had seen this pattern before. The constellation of symptoms and the diagnostic odyssey. The implants sat entirely outside the clinical frame while the rest of her body was being interrogated for explanations.
She represents an important pattern. Over years of clinical practice, I have seen this presentation enough times that I now ask about implants the way I ask about medications: early, systematically, as part of the foundational history. Most of the physicians these women saw before me did not ask at all.
She had explantation surgery eight months after that first appointment. Within ninety days, her fatigue had lifted significantly. The joint pain was gone. The brain fog cleared. She sent me a message that said: I feel like myself again.
I am a physician with over 30 years of clinical experience. I have been practicing precision and integrative medicine for over a decade. I did not learn about breast implant illness in medical school or residency. I learned about it from patients who had already spent years being told nothing was wrong with them. I have since built a clinical practice around it. I have written a methodology for it. I have worked to get a novel diagnostic biomarker into clinical testing. The gap between what the science now shows and what most women are being told is what compels me to write this post.
The symptoms of breast implant illness span nearly every organ system, which is part of why women spend years being passed from specialist to specialist without a diagnosis. Each physician sees one aspect in a silo and calls it something else.
A 2022 prospective cohort study of 467 women at the Amsterdam University Medical Centers (UMC), one of the largest and most methodologically rigorous datasets available, found the following symptom frequencies: fatigue in 88 percent of patients, joint pain in 71 percent, morning stiffness in 59 percent, muscle pain in 48 percent, cognitive impairment in 33 percent, peripheral neurological symptoms in 30 percent, and lymphadenopathy in 22 percent. [2]
A separate meta-analysis across 6,048 patients found fatigue in 58 percent, joint pain in 51 percent, muscle pain in 44 percent. [3]
An international Delphi consensus panel including plastic surgeons, researchers, patient partners, and an FDA representative reached agreement on six core symptoms for a standardized BII severity scale: fatigue, cognitive impairment, joint pain, muscle pain, hair loss, and skin rash. The full consensus list extended to 19 symptoms spanning constitutional, musculoskeletal, neurological, dermatologic, and psychological domains. [4]
An analysis of 10 years of FDA MAUDE database reports found that the three most commonly reported symptom categories were neurological symptoms in 72.4 percent, musculoskeletal symptoms in 55.7 percent, and dermatologic symptoms in 36.4 percent. Hierarchical clustering analysis showed that symptoms grouped into two distinct patterns, suggesting that BII may represent at least two separate clinical phenotypes rather than one uniform syndrome. [5]
Two findings from the research complicate straightforward attribution, and intellectual honesty requires including them. A 2025 Dutch multicenter cohort study of 9,590 breast cancer survivors found that those with silicone implant reconstructions did not report more BII-associated symptoms than breast cancer survivors without implants: 20.7 percent versus 21.2 percent reporting four or more symptoms. [6] A separate 2025 meta-analysis found that 51 percent of women presenting with BII symptoms had other explainable diagnoses or contributing etiologies, including autoimmune conditions in 20.7 percent, psychiatric illness in 16.5 percent, and fibromyalgia in 12 percent. [7]
Neither finding rules out BII. The Dutch study compared women with implants after breast cancer to other breast cancer survivors, who may already have a high symptom burden from surgery and treatment. The meta-analysis shows that clinicians should look carefully for other causes before blaming every symptom on implants.
Neither study answers the central question: what about women with no other diagnosis whose symptoms improve after their implants are removed, yet were never given a meaningful explanation?
Symptoms appear on average 6.4 years after implantation. Explantation occurs on average 12.3 years after placement. [3] That represents about six years of diagnostic drift and nearly twelve years of living with a device that the medical system usually fails to connect to the illness it may be causing.
Breast implant illness is not an official medical diagnosis. It has no ICD code, no validated diagnostic criteria, no agreed-upon biomarker, [8] which is frequently used as a reason to dismiss it. The argument runs: if it were real, medicine would have named it by now.
That argument ignores how medicine has historically treated contested illness in women. Fibromyalgia spent decades as a psychiatric diagnosis before the research caught up. Endometriosis even to this day takes an average of seven to ten years to diagnose in the United States. Dysautonomia, ME/CFS, chronic Lyme.
The pattern is consistent. Women present with symptoms that do not fit a clean diagnostic category. Medicine calls it anxiety. The research, when it eventually arrives, finds something else entirely.
The research has now arrived.
A 2026 systematic review found 98 symptoms reported across 23 studies of women who believed their breast implants were making them sick. [8] About 1.5 million women receive implants worldwide each year. [1] Even using conservative estimates, roughly 6.6 million women may eventually need them removed. [3] Yet the medical system is barely prepared to care for them. The FDA does not currently recommend prophylactic removal or screening in asymptomatic patients.
What I was taught: What I was taught: Breast implants are FDA-approved medical devices with a strong safety record. Symptoms after implant placement, whether for cosmetic augmentation or reconstruction after breast cancer, are usually blamed on surgical complications, body image concerns, cancer treatment, or mental health conditions.
What I now understand: The absence of an official diagnosis is not the same as the absence of a condition, particularly in women. You can develop systemic symptoms after breast implant placement for any reason, including cosmetic augmentation, reconstruction, revision surgery, or prophylactic mastectomy. The FDA now requires every patient to be warned that breast implants may cause systemic symptoms. [9] That warning exists because the evidence became impossible to ignore. The dismissal of women’s experience came first, and it has not fully ended.
★ The rest of this post continues for paid subscribers ★
You now know that breast implant illness is real, that the FDA was compelled to act, and that mainstream medicine’s failure to name it follows a pattern every woman with a contested diagnosis will recognize. Women report what is happening in their bodies, and the medical system looks for reasons not to believe them.
The FDA has acknowledged the risk of systemic symptoms. Yet many women are still told that their fatigue, joint pain, brain fog, rashes, hair loss, and immune symptoms are unrelated, unexplained, or psychological.
However, recognition is only the beginning.
The questions that matter now are more personal: Why do some women become sick while others do not? How can an implant in the breast affect the brain, joints, skin, immune system, and nervous system? What are the cancer risks that patients were not warned about for years? And how do you determine whether your implants are actually contributing to your symptoms?
Below, I explain the biology, including biofilm, chronic immune activation, cytokines, and HLA susceptibility. I also walk you through the FDA consent checklist your surgeon should have reviewed with you, how to evaluate your symptoms, when explantation may be reasonable, and what the evidence says about en bloc removal, capsulectomy, and recovery.
This is the clinical framework I have built over years of caring for women in this exact situation. It is designed to help you move from suspicion and dismissal to evidence, clarity, and an informed decision about what happens next.
